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32 The Journal of Thoracic and Cardiobjective: If lungs could be retrieved from non–heart-beating donors, the critical
hortage of lungs for transplantation could be alleviated. However, lungs subjected
o warm ischemia develop edema when reperfused. We hypothesized that ventila-
ion of rat lungs from non–heart-beating donors with nitric oxide during the period
f warm ischemia alone, with reperfusion, or both might reduce ischemia-reperfu-
ion injury.
ethods: An isolated perfused rat lung model measured the filtration coefficient and
ccumulation of lung water by the wet/dry weight ratio. Donor rats were euthanized,
nd then lungs were retrieved immediately after death or 2 or 3 hours postmortem.
ungs retrieved postmortem were either not ventilated or ventilated with 100%
xygen alone or 40 ppm nitric oxide in oxygen. In the circuit, lungs were ventilated
ith alveolar gas with or without 40 ppm nitric oxide.
esults: Nitric oxide administration to the non–heart-beating donor or in the
erfusion circuit reduced filtration coefficient and wet/dry weight ratio. Lungs
etrieved 2 hours postmortem ventilated with nitric oxide or treated with nitric oxide
n reperfusion had filtration coefficients and wet/dry weight ratios similar to those
f lungs retrieved immediately after death. Nitric oxide was most beneficial when
dministered both during warm ischemia and at reperfusion in lungs retrieved 3
ours postmortem. Nitric oxide administration in the circuit was associated with
ncreased lung levels of lung cyclic guanosine monophosphate, determined by
nzyme-linked immunosorbent assay.
onclusions: Administration of nitric oxide to non–heart-beating donors during warm
schemia and with reperfusion might facilitate transplantation of lungs from non–heart-
eating donors by reducing ischemia-reperfusion injury and capillary leak.
ung transplantation is an effective therapy to palliate patients with end-stage
lung disease, but widespread use is severely limited by an inadequate supply
of suitable lungs from conventional organ donors. If lungs could be retrieved
rom non–heart-beating donors (NHBDs), the critical shortage of lungs for trans-
lantation could be alleviated.1 However, this strategy might be limited by isch-
mia-reperfusion injury (IRI) due to unavoidable warm ischemic time in the de-
eased donor.
The critical shortage of donor lungs has prompted our laboratory to investigate the
se of NHBDs in experimental models of lung transplantation.1-3 We have used an
solated perfused rat lung model (IPRLM) to measure changes in filtration coefficient
Kfc) in the Starling equation to assess the early phase of IRI in rat lungs obtained from
HBDs.4 Lungs retrieved 2 hours postmortem had substantially increased capillary
eak, which was manifested by increased Kfc and wet/dry weight ratios (W/D).
Nitric oxide (NO) donors can reduce IRI, presumably due to endothelial synthe-is of NO, a potent vasodilator that inhibits neutrophil adhesion, platelet aggrega-
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TXion, and endothelial cytokine-induced activation.5 These
ffects are mediated by NO stimulation of guanylate cy-
lase, converting guanosine triphosphate to guanosine 3=, 5=
onophosphate (cGMP). Levels of endogenous NO and
GMP are quickly reduced during IRI.6 Inhaled NO reduced
fc and neutrophil activation in isolated blood-perfused rat
ungs.7 Reperfusion of lungs retrieved from NHBDs with
he NO donor nitroglycerin (NTG) reduced Kfc and W/D
atios, allowed for Kfc assessment of nonventilated cadaver
ungs retrieved 3 hours postmortem, and was associated
ith an increase in lung tissue levels of cGMP.8 The airway
rovides an avenue for delivery of oxygen and potentially
or delivery of other therapeutic agents that might reduce
ubsequent IRI in lungs from NHBDs. Therefore, the
resent study was designed to assess the effect of NO
dministration to lungs after circulatory arrest, during reper-
usion, or both in the IPRLM.
aterials and Methods
PRLM
he specific details of our IPRLM have been outlined previously.4
riefly, male Sprague-Dawley rats weighing 250 to 450 g were
nesthetized with intraperitoneal pentobarbital sodium (35 mg/kg;
bbott Laboratories, Chicago, Ill). Heparin (600 units) (Elkins-
inn, Cherry Hill, NJ) was injected intrahepatically, and the tra-
hea was cannulated with p60 tubing. The rat was then euthanized
ith a lethal intrahepatic injection of pentobarbital sodium (120
g/kg). The heart-lung block was left in situ to simulate the
HBD clinical scenario as closely as possible. At intervals after
eath, the lungs were removed and reperfused in the IPRLM.
ircuit perfusate was Earle’s balanced salt solution containing 2.4
mol CaCL2 · 2H2O, 0.4 mmol MgSO4 (anhydrous), 5.4 mmol
Cl, 116 mmol NaCl, 0.88 mmol NaH2PO4 (anhydrous), 5.5
mol D-glucose, and 0.3 mmol phenol red containing 0.21%
aHCO and 4% bovine serum albumin (Sigma Chemical, St
Abbreviations and Acronyms
cAMP  cyclic adenasine monophosphate
cGMP  guanosine 3=, 5= monophosphate
IPRLM  isolated perfused rat lung model
IRI  ischemia-reperfusion injury
Kfc  filtration coefficient
NHBD  non–heart-beating donor
NO  nitric oxide
NO-D  inhaled NO during the ischemic interval
alone
NO-DR inhaled NO during both the ischemic
interval and reperfusion
NO-R  inhaled NO during reperfusion alone
NTG  nitroglycerin
PEEP  positive end-expiratory pressure
Ppv  pulmonary venous pressure
W/D  wet/dry weight ratio3
ouis, Mo). Rat lungs were ventilated in the IPRLM with alveolar c
The Journal of Thoracicas (5% CO2, 20% O2, balance N2) at 60 breaths/min, a tidal
olume of 3 mL, and positive end-expiratory pressure (PEEP) of 2
m H2O. When NO was administered in the IPRLM circuit (in-
aled NO during reperfusion alone [NO-R] and inhaled NO during
oth the ischemic interval and reperfusion [NO-DR]), the lungs
ere ventilated with 40% flow from a tank containing 100 ppm
O in N2 and 60% flow from a custom gas mixture (8% CO2, 33%
2, balance N2) to render a gas composition of 5% CO2, 20% O2,
alance N2 with 40 ppm NO. The concentration of NO was
onitored continuously just proximal to the endotracheal tube by
sing chemiluminescence analyzers (Freedom 5000; Scott Instru-
ents, Exton, Pa). Perfusate temperature was maintained at be-
ween 35°C and 38.5°C, and perfusate pH was continuously mon-
tored with a pH probe (Accumet; Fisher Scientific, Pittsburgh, Pa)
n the venous reservoir. The pH was maintained near 7.40 by
dding diluted HCl or NaHCO3 as necessary.
pecific Protocol
ixty pairs of lungs were divided into 10 groups (n 6 per group).
wo groups served as controls, with lungs retrieved immediately
fter euthanasia and reperfused within 5 minutes of death, venti-
ated in the IPRLM with alveolar gas or ventilated in the IPRLM
ith 40 ppm NO, 5% CO2, and 20% O2 (0h NO-R). Four groups
ad lungs retrieved 2 hours postmortem: nonventilated control
ungs (2h NV), lungs from nonventilated NHBDs ventilated in the
PRLM with NO (2h NO-R), lungs ventilated in the NHBD with
O (2h NO-D) and then evaluated in the IPRLM without NO, and
ungs ventilated both after euthanasia and in the IPRLM (2h
O-DR). In earlier studies lungs retrieved from cadavers venti-
ated for 2 hours with oxygen had similar Kfc values and W/D
atios as lungs retrieved 2 hours postmortem from nonventilated
nimals,4,8 and therefore studies of this group were not repeated.
or NHBDs, NO was administered into the inspiratory limb of the
espirator circuit as a mixture of 100 ppm in pure nitrogen (at 40%
otal flow) with 100% O2 at 60% flow for a concentration of 60%
2 plus 40 ppm NO at 60 breaths/min, a tidal volume of 3 mL, and
PEEP of 2 cm H2O. Four groups had lungs retrieved 3 hours
ostmortem: control lungs were ventilated in the NHBD with
00% O2 (3h O2-vent) nonventilated NHBDs ventilated in the
PRLM with NO (3h NO-R), lungs ventilated in the NHBD with
O (3h NO-D) and then evaluated in the IPRLM without NO, and
ungs ventilated both after euthanasia and in the IPRLM (3h
O-DR). Nonventilated lungs retrieved 180 minutes postmor-
em and not treated with NO could not be included because of
onsistent development of pulmonary edema (n  6). All animals
eceived humane care in accordance with the “Guide for the Care
nd Use of Laboratory Animals” (National Institutes of Health
ublication no. 85-23, revised 1985).
ulmonary Hemodynamics and Airway Pressure
ressure transducers recorded pulmonary arterial (Ppa), venous
Ppv) and airway (Paw) pressure continuously. All pressure mea-
urements and changes in weight gain were recorded by using the
ab View SCXI Pressure Weight Acquisition System (National
nstruments, Austin, Tex) on a Gateway E-3400 computer. Pul-
onary arterial resistance (Rpa) and venous resistance (Rpv) werealculated according to the following formulas:
and Cardiovascular Surgery ● Volume 132, Number 1 133
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1
TXRpa (Ppa Ppc) ⁄ Q and Rpv (Ppc Ppv ⁄ Q ,
here Q is flow in milliliters per minute.
etermination of Kfc
ulmonary capillary pressure (Ppc) measurement and calculation
f Kfc has been outlined in detail elsewhere.4 Briefly, Kfc is
alculated by log transformation of w between minutes 6 and 15
y using linear regression of the log-10 weight changes per minute
xtrapolated back to time zero after increasing the height of the
enous reservoir. The w/t between minutes 6 and 15 represents
ncreased transvascular fluid flux secondary to increased capillary
ermeability. Kfc is normalized by using baseline wet lung weight
nd expressed as milliliters per minute per centimeter H2O per
00 g of lung tissue.
/D Ratios
t the completion of the experiment, the upper lobe of the right
ung was excised and immediately weighed. It was then dried in a
0°C oven for 48 hours and reweighed, and the ratio was calcu-
ated. The remaining lung tissue was cut into multiple pieces,
nap-frozen in liquid nitrogen, and stored at 80°C until subse-
uent extraction and analysis.
igh-performance Liquid Chromatography
issue samples retrieved from the right lung underwent ice-cold
.6N perchloric acid extraction and measurement of adenine nu-
leotides by HPLC using a Beckman System Gold apparatus
Beckman Instruments, Fullerton, Calif), as previously described.8
alues were corrected for lung water content by expressing results
s micromoles per gram of dry weight.
GMP Determinations
GMP was analyzed by using the Biotrak enzyme immunoassay
EIA) system from Amersham Biosciences Corp (Code RPN 226)
Buckinghamshire, UK) after extraction, as described previously.8
ata were corrected for water content by calculating the W/D ratio
rom a frozen portion of each sample, and results were expressed
s femtomoles of cGMP per milligram of dry weight.
tatistics
tatistical analysis was performed by using analysis of variance
ith the Tukey’s post-hoc test for multiple comparisons for groups
f lungs studied 120 and 180 minutes postmortem or an unpaired
test for lungs studied immediately after death (with and without
O ventilation in the circuit). Separate analyses of variance
ANOVAs) with the Tukey post-hoc test for multiple comparisons
ere performed across time points for the same conditions (with or
ithout NO) by using Statistica (Tulsa, Okla). Calculation of
eans, standard errors, and logistic regression were performed
ith Excel 2000 (Microsoft, Redmond, Wash). All values are
eported as the mean  standard error of the mean. Differences
ere considered significant when P  .05.
esults
fc
ifferences in the Kfc are shown in Figure 1. Lungs re-rieved immediately after death had normal Kfc values (0.3 I
34 The Journal of Thoracic and Cardiovascular Surgery ● JulyL/min/cm H2O/100g lung weight), irrespective of whether
hey were ventilated in the IPRLM circuit with NO. In lungs
etrieved 2 hours postmortem, Kfc was markedly increased
n nonventilated nontreated lungs (control). Inhaled NO
uring reperfusion (NO-R) or during the ischemic interval
lone (NO-D) decreased the Kfc value significantly, as did
he combination of NO administration during ischemia and
ith reperfusion (NO-DR). Although the Kfc value was
odestly increased in NO-treated lungs retrieved 2 hours
ostmortem compared with that seen in lungs assessed
mmediately postmortem, these differences did not reach
tatistical significance. In lungs retrieved 3 hours postmor-
em, the Kfc value was not measurable in nonventilated
ungs because of pulmonary edema. The Kfc value could be
easured in O2-ventilated cadavers studied 3 hours post-
ortem and was markedly elevated. Inhaled NO during
oth periods of warm ischemia (NO-D) or reperfusion
NO-R) decreased the Kfc value compared with O2 venti-
ation of cadavers alone, and the Kfc value was significantly
educed when NO was administered both during ischemia
nd with reperfusion (NODR).
/D Ratio
ifferences in W/D ratios are shown in Figure 2. Lungs
etrieved immediately after death had normal W/D rations
5.8), irrespective of whether they were ventilated with NO.
igure 1. Filtration coefficient (Kfc) values increased with in-
reasing postmortem ischemic time, but the increase was dimin-
shed by ventilation with 40 ppm nitric oxide (NO) during the
schemic interval (D) or with reperfusion (R). The effect of NO
entilation during both the ischemic interval and with reperfusion
DR) resulted in substantial attenuation of Kfc values in lungs
tudied 3 hours after death. Although Kfc values increased with
ostmortem ischemic time, when NO was administered both
uring ischemia and with reperfusion (DR), the increase was
ot statistically significant. Mean  standard error of the mean,
 6 per group. *P < .05 compared with other groups at the
ame postmortem time interval. #P < .05 compared with appro-
riate time 0 group.n lungs retrieved 2 hours postmortem, W/D ratios were
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TXarkedly elevated in the nonventilated group not treated
ith NO. Inhaled NO during reperfusion or during ischemia
ad similar effects on W/D ratios and Kfc values. The effect
f NO administration on W/D ratios was most marked when
t was administered during ischemia and reperfusion (NO-
R). In lungs retrieved 3 hours postmortem, W/D ratios
ere markedly increased in the absence of NO treatment.
nhaled NO during either warm ischemia or reperfusion
ecreased W/D ratios, with a significant reduction observed
hen NO was administered both during warm ischemia and
ith reperfusion (NO-DR, P  .05) compared with O2
entilation alone.
The relationship between Kfc values and W/D ratios is
epicted in Figure 3. There was an excellent correlation
etween Kfc values and W/D ratios, supporting the hypoth-
sis that the Kfc value was associated with capillary leak
eading to pulmonary edema.
emodynamics
emodynamic data are shown in Table 1. The changes in
fc values and W/D ratios cannot be explained by minimal
ifferences in vascular pressures or resistance.
denine Nucleotides
ung levels of adenine nucleotides are shown in Table 2.
denosine triphosphate (ATP) and adenosine monophos-
hate plus adenosine diphosphate plus adenosine triphos-
hate (TAN) levels were significantly reduced in some
roups of lungs retrieved 2 or 3 hours postmortem com-
ared with lungs retrieved immediately. The benefit of NO
reatment on Kfc values and W/D ratios cannot be attributed
igure 2. Wet/dry weight ratio (W/D) reflects edema fluid accu-
ulation and showed a pattern similar to that seen with the
ltration coefficient (Kfc). Administration of 40 ppm nitric oxide
NO) during the ischemic interval (D) or with reperfusion (R)
educed the amount of edema in lungs retrieved from NHBDs.
ean  standard error of the mean, n  6 per group. *P < .05
ompared with other groups at the same postmortem time inter-
al. #P < .05 compared with appropriate time 0 group.o improved tissue levels of adenine nucleotides. h
The Journal of ThoracicGMP
igure 4 shows that cGMP levels in lung tissue were higher
n lungs ventilated with NO in the circuit (NO-R or NO-
R). If NO was administered to the cadaver but not
ontinued with reperfusion (NO-D), lung cGMP levels were
lightly but not significantly elevated, implying that the
ffect of NO ventilation on lung tissue cGMP levels was
ransient and not sustained after reperfusion for 30 minutes
n the absence of NO ventilation. cGMP levels increased in
ontreated lungs with increasing postmortem ischemic time.
y 3 hours, this difference, although modest, was signifi-
ant when compared with levels found in lungs retrieved
mmediately after death.
iscussion
f lungs could be retrieved from NHBDs hours after death
nd successfully transplanted, the critical shortage of lungs
or transplantation could be alleviated. Experimental evi-
ence supporting the potential use of lungs from NHBDs
igure 3. Relationship between filtration coefficient (Kfc) and
et/dry weight ratio (W/D) A, for all experiments (n  60, P <
00001) and B, for the individual groups (P < .002).as been reviewed.9 Although cessation of the circulation
and Cardiovascular Surgery ● Volume 132, Number 1 135
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1
TXith cardiac arrest promptly leads to irreversible ischemia
nd cell death in other organs, this process might be delayed
n the lung because the lung parenchyma does not rely on
ascular perfusion for cellular respiration. Rather, it would
ppear that cellular respiration occurs directly across the
lveolar wall, and gas exchange processes are entirely pas-
ive. Pulmonary epithelial tissue retrieved from morgue
pecimens is routinely successfully cultured, supporting the
ypothesis that some human lung tissue remains viable for
everal hours after circulatory arrest and death.
Despite improved preservation techniques, IRI to the trans-
lanted lung remains a significant problem in the early post-
perative period. In the lung, IRI is manifest as an orchestrated
eries of events,10 some occurring very early after reperfusion
nd others occurring much later, perhaps related to alterations
n gene transcription and protein expression.
The IPRLM is a very sensitive measure of pulmonary
apillary function and has been used extensively to character-
able 1. Hemodynamic data
ime postmortem
min) NO PA (mm Hg)
min None 6.82 0.26
R 6.97 0.53
20 min Nonventilated 7.22 0.58
D 12.63 1.0*†
R 8.41 0.64
DR 8.57 0.67
80 min O2 ventilated 9.79 0.51†
D 9.14 0.52
R 7.76 0.45
DR 8.2 0.48
ll values are reported as mean  standard error of the mean. NO, Nitr
ulmonary arterial resistance; RV, pulmonary venous resistance; R, recipie
ime. †P  .05 compared with time zero with or without NO (by analysis
able 2. Adenine nucleotides
ime
ostmortem NO AMP 
min None 1.07  0.32
R 0.86  0.3
20 min Nonventilated 0.7  0.34
D 0.99  0.58
R 0.74  0.26
DR 0.43  0.83
80 min O2 ventilated 0.72 0.33
D 0.54  0.21
R 0.41  0.15
DR 0.48  0.14
ll values are presented as mean  standard error of the mean in microm
DP, adenosine diphosphate; ATP, adenosine triphosphate; TAN, AMP 
ime (unpaired t test). †P  .05 compared with time zero with or without NO (b
36 The Journal of Thoracic and Cardiovascular Surgery ● Julyze the early response of the pulmonary microcircula-
ion to ischemia, followed by reperfusion or hypoxia-
eoxygenation.11,12 We have used this model to characterize
he time course of early changes in permeability with reperfu-
ion in rat lungs left in situ for intervals after circulatory arrest
nd death.4 By leaving lungs in situ after the animal was
uthanized, instead of the alternative of harvesting, immediate
erfusion, and then making the lung ischemic, our model more
losely resembles the clinical scenario of the NHBD. We have
hosen to administer heparin in donors before death so that we
an evaluate the effect of ischemia alone on capillary function.
n the clinical scenario of lung retrieval from NHBDs, it might
e possible to administer heparin in potential donors after death
y means of intracardiac injection and a brief period of car-
iopulmonary resuscitation to distribute heparin to the pulmo-
ary microcirculation.
The asanguineous nature of this model is a particular
trength because it demonstrates the effects of reperfusion
PV (mm Hg)
RA (mm Hg/
mL/min1)
RV (mm Hg/
mL/min1)
0.50  0.12 0.4  0.06 0.28 0.04
0.56  0.04 0.38  0.02 0.35  0.03
0.45  0.15 0.43  0.04 0.32  0.05
0.32  0.05† 0.38 0.04 0.48  0.04
0.55  0.13 0.51  0.03† 0.47  0.09
0.44  0.07 0.44  0.05 0.46  0.03
0.29 0.07 0.47  0.04 0.34  0.02
0.38  0.05 0.31  0.03† 0.34  0.05
0.42  0.03 0.33  0.03 0.37  0.05
0.41 0.06† 0.42 0.05 0.41  0.06
de; PA, pulmonary artery pressure; PV, pulmonary venous pressure; RA,
donor. *P  .05 compared with others at the same postmortem ischemic
iance with Tukey’s correction).
ADP ATP TAN
1.97 0.23 3.05 0.07* 6.1 0.28*
1.48 0.39 2.4  0.28 4.75  0.54
1.22  0.68 1.93 0.34† 3.86  0.81†
1.10 0.27 1.73 0.27 3.83  0.61
1.22 0.14 1.58 0.41 3.56  0.46
1.37 0.29 1.45 0.68 3.25  0.39
1.53 0.30 1.97 0.32† 4.24  0.61
0.46 0.05 1.43 0.19 2.45  0.07†
0.72 0.13 1.91 0.24 3.05  0.41
0.97 0.38 1.38 0.15 2.85  0.41†
er gram of dry weight. NO, Nitric oxide; AMP, adenosine monophosphate;
ATP. *P  .05 compared with others at the same postmortem ischemicic oxi
nt; D,oles p
ADP y analysis of variance with Tukey’s correction).
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TXf ischemic lung tissue in a leukocyte-free environment.
lthough it can be argued that this is artificial, the foreign
urface in the tubing and exposure to air in the reservoir
ould likely activate platelets and leukocytes. Red blood
ells are a source of superoxide dismutase, which could
unction as a free radical scavenger. By using colloid-
upplemented crystalloid as perfusate, any effects on lung
eight gain must be related to either endothelial integrity to
ontain fluid in the vascular space or impaired epithelial
learance of fluid that has leaked into the alveolar space.
liminating blood components allows the model to focus on
he role of pulmonary parenchymal cells in the early phase
f reperfusion injury that appears to be important for edema
ccumulation. In earlier canine lung transplant experiments
rom NHBDs, increased accumulation of extravascular lung
ater early after transplantation was associated with an
ltered A-a gradient.2 Therefore it is important to identify
trategies that will minimize early capillary leak in lungs
etrieved from NHBDs.
Using this model, we demonstrated that agents that in-
rease cyclic adenosine monophosphate (cAMP) levels (iso-
roterenol) or decrease cyclic adenosine monophosphate
reakdown (phosphodiesterase inhibitor rolipram) adminis-
ered during reperfusion of lungs retrieved from NHBD rats
educed the increase in Kfc value and edema (W/D ra-
io).13,14 Reperfusion of lungs retrieved from NHBDs with
he NO donor NTG resulted in similar mitigation of the
xpected increase in Kfc values and W/D ratios.8 With NTG
n the reperfusate, it was possible to measure the Kfc values
n nonventilated lungs retrieved 3 hours after death, whereas
ntreated lungs developed florid pulmonary edema and
igure 4. Lung tissue guanosine 3=, 5=monophosphate (cGMP)
evels increased when nitric oxide (NO) was administered in the
solated perfused rat lung model (IPRLM); ie, when NO was being
dministered to the lungs up until their retrieval and freezing.
ean  standard error of the mean, n  6 per group. *P < .05
ompared with other groups at the same postmortem time inter-
al. #P < .05 compared with appropriate time 0 group.ould not reach an isogravimetric state in the IPRLM. r
The Journal of ThoracicIn lungs retrieved 2 hours postmortem, Kfc values and
/D ratios were markedly elevated in untreated lungs.
nhaled NO during reperfusion or during warm ischemia
ecreased Kfc values and W/D ratios. In lungs retrieved 3
ours postmortem, the best results were obtained when NO
as administered to the NHBD during both ischemia and
eperfusion, with dramatic attenuation of increased Kfc
alues. This is an extremely important observation because
entilation of an NHBD with 40 ppm NO is a practical
ption in the clinical setting while arrangements are made to
etrieve the lungs for assessment of transplant suitability.
In lungs retrieved 2 hours postmortem, NO administra-
ion had similar effects on Kfc values and W/D ratios as
TG reperfusion in our earlier study.8 However, in lungs
etrieved 3 hours postmortem, reperfusion with NTG only
odestly improved Kfc values and W/D ratios, whereas
dministration of NO during 3 hours of ischemia and with
eperfusion dramatically reduced both Kfc values and W/D
atios.
Administration of NO (40 ppm) to canine recipients of
ungs retrieved 3 hours postmortem from nonventilated
HBDs was associated with dramatic improvement in ox-
genation and pulmonary vascular resistance during 6 hours
f posttransplant observation.15 The benefit of NO admin-
stration was apparent, even if the agent was discontinued
fter only 1 hour of reperfusion. Murakami and colleagues7
lso demonstrated a benefit of NO administration in both
orcine and rat models of lung transplantation from
HBDs, but the ischemic time was considerably shorter
han ours. Luh and associates16 demonstrated a benefit of
O administration (20 ppm) before the onset of 2 hours of
schemia and NO administration with reperfusion in an ex
ivo model using lungs from minipigs. Using a rabbit ex
ivo lung perfusion model, Schutte and coworkers17
howed a beneficial effect of NO administration (10 ppm)
efore the onset of ischemia or with reperfusion on weight
ain, and a benefit of NO (10 ppm) or 8-bromo cGMP
dministration with reperfusion to reduce Kfc values. Ai-
chison and colleagues18 showed a benefit of NO adminis-
ration in an ex vivo circuit after intervals of warm ischemia,
ocumented by superior performance after transplant by
sing a porcine model. Our study shows that administration
f NO during the period of warm ischemia in the NHBD
ight be even more beneficial.
NO was initially known as endothelium-dependent relaxing
actor, a potent vasodilator and an endogenous stimulator of
oluble guanylate cyclase, which produces cGMP. Cyclic
MP regulates 3 classes of effector proteins: cGMP-dependent
rotein kinases, cGMP-gated ion-channel protein kinases, and
hosphodiesterases, mediating protein phosphorylation, cation
nflux, and cyclic nucleotide catabolism.19
NO is diminished in endothelial cells after ischemia and
eperfusion and after hypoxia-reoxygenation.6,20 The NO
and Cardiovascular Surgery ● Volume 132, Number 1 137
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1
TXathway plays a pivotal role in the regulation of microcir-
ulation flow and vascular permeability associated with IRI.
xogenous NO donors reverse increased microvascular per-
eability and reduce pulmonary injury as a consequence of
schemia and reperfusion.21 In addition, administration of
O donors or NO itself has been shown to reduce polymor-
honuclear leukocytes influx after pulmonary reperfusion.22
O inhibits neutrophil activation, aggregation, and migra-
ion23 and reduces cytokine-induced adhesion molecule ex-
ression.5 In addition, NO might inhibit inflammatory cy-
okine production by lung macrophages.24 Thus exogenous
O administration might reduce lung IRI and improve
onor lung function through several mechanisms. Despite
he potential role of NO to reduce lung IRI, in the clinical
etting of human lung transplantation from conventional
onors, only modest or no demonstrable benefit has been
bserved,25 although there was a substantial benefit in a
orcine model of lung transplantation26 and when adminis-
ered before warm in situ lung ischemia.27
In our study, administration of NO during reperfusion
as associated with increased tissue levels of cGMP as-
essed by means of enzyme-linked immunosorbent assay of
hole-lung extracts. If NO was administered to the NHBD
uring ischemia but not during reperfusion in the IPRLM,
e could not demonstrate significant increases in cGMP
evels after more than 30 minutes of perfusion, implying
hat the effect of exogenous NO administration is short-
ived vis à vis its effect on guanylate cyclase. cGMP levels
ere higher in untreated lungs retrieved and perfused 3
ours postmortem. We saw a similar pattern in an earlier
tudy, when cGMP was measured in lungs reperfused with
r without NTG.8 Perhaps in the lung guanylate cyclase is
timulated by the stress of ischemia.
There were minimal differences in vascular pressures
nd resistance among almost all groups in our study. This
uggests that pulmonary vasodilation is not contributing to
he attenuation of IRI due to NO in lungs from NHBDs.
ecause the IPRLM is asanguineous, the effect of NO we
bserved is unrelated to inhibition of neutrophil adherence
nd the subsequent production of capillary wall damage.
he effect is apparent relatively immediately with reperfu-
ion and appears to be related to provision of NO to the
schemic graft, consistent with the notion that during isch-
mia, lung endothelial cells are deficient in NO.20 In earlier
tudies we showed a relationship between total adenine
ucleotide levels in lung tissue and lung parenchymal cell
iability28 and Kfc values with reperfusion in untreated
ungs.13 In the current study the beneficial effect of NO
entilation was unrelated to tissue levels of adenine nucle-
tides (Table 2).
This study shows that a simple therapeutic intervention
elivered through the airway to a dead animal can have a
rofound effect on lung microvascular function assessed 3
1
38 The Journal of Thoracic and Cardiovascular Surgery ● Julyours after death. Ventilation of a cadaver with NO would
e easy to perform in the setting of lung retrieval from a
uman NHBD. Because of the myriad ways in which hu-
ans die, variable warm ischemic time, and other factors
hat might influence lung function, some method of ex vivo
valuation of lungs retrieved from NHBDs will likely be
ecessary if transplantation of lungs from NHBDs is to be
idely applied in the clinical setting. Indeed, ex vivo eval-
ation was considered essential when one such transplanta-
ion was performed by Steen and associates29 in Sweden.
uch a system of ex vivo perfusion and ventilation would
rovide another opportunity to treat the graft with NO
entilation or other maneuvers. Determining practical meth-
ds to reduce the effect of reperfusion on the ischemic lung
ill facilitate the introduction of lung transplantation from
HBDs and has the potential to allow much broader appli-
ation of lung transplantation to all patients with end-stage
ung disease.
We thank Dr Scott A. Schlidt for technical assistance; Dr C. E.
avis, Professor of Biostatistics at UNC, for assistance with sta-
istical analysis; and Margaret A. Cloud for editorial assistance in
he preparation of this manuscript.
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